Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease

INTRODUCTION: Trials in Alzheimer's disease (AD) now include participants at the earliest stages to prevent further decline. However, the lack of tools sensitive to subtle functional changes in early-stage AD hinders the development of new therapies as it is difficult to prove their clinical re...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Alzheimers Dement (N Y)
Egile Nagusiak: Villeneuve, Sarah-Christine, Houot, Marion, Cacciamani, Federica, Verrijp, Merike, Dubois, Bruno, Sikkes, Sietske, Epelbaum, Stéphane
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2019
Gaiak:
Featured Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804616/
https://ncbi.nlm.nih.gov/pubmed/31650012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.08.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak